Clinical trial · Observational
Predictors of Recurrence for High Risk Endometrial Cancer Patients
NCT04412902CI-TRIAL-00048730completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will analyze whether there is any difference in recurrence and survival rates among the patients who received different adjuvant therapies.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| High-risk Endometrial Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| adjuvant therapy | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Factors affecting overall survival
- timeFrame
- 10 years
- description
- Factors affecting overall survival
Secondary outcomes (1)
- measure
- Factors affecting progression-free survival
- timeFrame
- 10 years
- description
- Factors affecting progression-free survival
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: * All patients with high risk stage I endometrial cancer and all patients with stage II and stage III endometrial cancer and who underwent therapy in Far Eastern Memorial Hospital from 2009/01/01\~2019/09/17. Exclusion Criteria: * Patients with stage I endometrial cancer do not have high risk factors.
References
Publications (0)
Data not yet available
No reference posted for this study.